There are multiple challenges in treating patients with amelogenesis imperfecta (AI). When we think about pediatric patients, this becomes much more obvious. This case series report addresses different case reports of pediatric patients who present with imperfect amelogenesis. Patients with type I hypoplastic amelogenesis imperfecta, hypomaturation type amelogenesis imperfecta, and sporadic hypoplastic and hypomaturation type amelogenesis imperfecta were identified as cases I, II, and III, respectively. This case series has covered several therapies
No takes yet. Share an insight, caveat, or question.
Jome et al. (2024) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: